Literature DB >> 5689828

The isolation and identification of the urinary oxidative metabolites of metronidazole in man.

J E Stambaugh, L G Feo, R W Manthei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5689828

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  23 in total

1.  Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.

Authors:  B A Wood; A M Monro
Journal:  Br J Vener Dis       Date:  1975-02

2.  The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst.

Authors:  Robin E Pearce; Michael Cohen-Wolkowiez; Mario R Sampson; Gregory L Kearns
Journal:  Drug Metab Dispos       Date:  2013-06-27       Impact factor: 3.922

3.  Inhibition and induction of metronidazole and antipyrine metabolism.

Authors:  S Loft; J Sonne; H E Poulsen; K T Petersen; B G Jørgensen; M Døssing
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Pharmacokinetics of metronidazole as determined by bioassay.

Authors:  E D Ralph; J T Clarke; R D Libke; R P Luthy; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

Review 5.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

7.  Influence of dose and route of administration on disposition of metronidazole and its major metabolites.

Authors:  S Loft; M Døssing; H E Poulsen; J Sonne; K L Olesen; K Simonsen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.

Authors:  T K Daneshmend; M Homeida; C M Kaye; A A Elamin; C J Roberts
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

9.  Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.

Authors:  P E Noker; L Simpson-Herren; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  1H nuclear magnetic resonance study of metronidazole metabolism by perfused rat liver.

Authors:  H Allars; M D Coleman; R S Norton
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.